Publications by authors named "Sean Devlin"

Claim this Profile
R
Real-world experience of belumosudil and belumosudil/ruxolitinib combination in steroid-refractory chronic graft-versus-host disease.
Gagan Raju, Moneeza Walji, David Nemirovsky, Sean Devlin, Ilan Goldstein

Bone Marrow Transplant· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insurance Barriers to High-Cost Anti-Infective Medications Post Allogeneic Hematopoietic Cell Transplant.
Stephen Eng, Grashma Vadakkel, Samantha Brown, Susan Murillo, Warren Fingrut, Sean Devlin

Transplant Cell Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphoma.
Xavier Deschênes-Simard, Maria Bromberg, Sean M Devlin, Mithat Gonen, Ofrat Beyar-Katz

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aging-related, senescence-associated secretory phenotype and allogeneic hematopoietic cell transplantation outcomes in older patients.
Mark Y Jeng, Phillip Wong, Jessica R Flynn, Erika Ritter, Caleb Ho, Sean Devlin

J Geriatr Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late hematologic toxicity after CAR T-cell therapy in large B-cell lymphoma: incidence, risk factors, and clinical impact.
Magdalena Corona, Samantha Brown, Kai Rejeski, Jessica R Flynn, Sean M Devlin

Bone Marrow Transplant· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic cell transplantation in acute myeloid leukemia not in complete remission: outcomes and prognostic factors in a contemporary cohort.
Shlomo Elias, Samantha Brown, Ogechukwu Egini, Moneeza Walji, Sylvester Homsy, Sean Devlin

Blood Cancer J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns and safety of glucocorticosteroid use following CD19 CAR-T therapy for large B-cell lymphoma.
Efrat Luttwak, David Nemirovsky, Sean M Devlin, Alexander P Boardman, Giulio Cassanello

Hemasphere· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia.
Yannis K Valtis, Chenyu Lin, David Nemirovsky, Sean M Devlin, Kai Rejeski

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States.
Curtis A Lachowiez, Georgios Asimomitis, Elsa Bernard, Sean M Devlin, Yanis Tazi

Blood Cancer Discov· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of CD19 CAR-T therapy in central nervous system lymphoma: Insights from a multicentre experience.
Giulio Cassanello, Efrat Luttwak, Samantha Brown, Sean M Devlin, Brandon Imber

Br J Haematol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell Lymphoma.
Jae H Park, M Lia Palomba, Karlo Perica, Sean M Devlin, Gunjan Shah

J Clin Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers to Chimeric Antigen Receptor T-Cell Therapy.
Yannis K Valtis, Kuo-Kai Chin, David Nemirovsky, Sean M Devlin, Meira Yisraeli Salman

JAMA Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies.
Sigrun Einarsdottir, Stephanie Lobaugh, Danny Luan, Marina Gomez-Llobell, Padmapriya Subramanian, Sean Devlin

Blood Cancer J· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Young people's perspective on the influence of alcohol, tobacco, vaping and fast food industries.
Joseph Dickenson, Sean Devlin

Future Healthc J· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantation.
Ioannis Politikos, Samantha Brown, Joshua A Fein, Stephen Eng, Kristian Casem, Sean Devlin

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Shared Care Model between community and transplant centers facilitates access to allogeneic and autologous transplantation.
Joshua A Fein, Agnes McAuliffe, Kimberly Fischer, Owen Brady, Sean M Devlin

Leuk Lymphoma· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphoma.
Magdalena Corona, Andrew Ip, Samantha Brown, Alejandro Luna, Hazim Khatib, Sean M Devlin

Bone Marrow Transplant· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma.
Alejandro Luna, Sean M Devlin, Kai Rejeski, Jessica R Flynn, Magdalena Corona

Blood Cancer J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapy.
Alexander P Boardman, Victoria Gutgarts, Jessica Flynn, Sean M Devlin, Adam Goldman

Haematologica· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Trial of MCARH109, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis.
Eric M Jurgens, Ross S Firestone, Jagrutiben Chaudhari, Kinga Hosszu, Sean M Devlin

J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-Related Values Discussions with Patients Undergoing Allogeneic and Autologous Stem Cell Transplant: Feasibility and Acceptability of an Early Primary Palliative Care Intervention.
Abigail G Cohen, Christina Cho, Emily Patterson, Jessica Magaldi, Tara Doga, Sean Devlin

Transplant Cell Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shift from Widespread to Tailored Antifungal Prophylaxis in Lymphoma Patients Treated with CD19 CAR T Cell Therapy: Results from a Large Retrospective Cohort.
Giovanna Melica, Alejandro Luna de Abia, Gunjan L Shah, Sean Devlin, Magdalena Corona

Transplant Cell Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes.
Yannis K Valtis, Sean Devlin, Roni Shouval, Kai Rejeski, Magdalena Corona

Blood Adv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal Residual Disease as an Early Endpoint for Accelerated Drug Approval in Myeloma: A Roadmap.
Ola Landgren, Sean M Devlin

Blood Cancer Discov· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring the impact of new risk factors within survival models.
Glenn Heller, Sean M Devlin

J R Stat Soc Ser C Appl Stat· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis